Zarontin 250 mg in 5 mL Oral Solution
RxNorm 755357
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 755357 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Zarontin 250 mg in 5 mL Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Ethosuximide 50 mg/ML Oral Solution [Zarontin]
(Atom ID: 12357868)
PSNPrescribable
Prescribable Name (PSN):
Zarontin 250 mg in 5 mL Oral Solution
(Atom ID: 8699784)
SYPrescribable
Synonym (SY):
Zarontin 250 mg per 5 mL Oral Solution
(Atom ID: 8699785)
SYPrescribable
Synonym (SY):
Zarontin 250 mg per 5 mL Oral Syrup
(Atom ID: 3801074)
SYPrescribable
Synonym (SY):
Zarontin 50 mg/ML Oral Solution
(Atom ID: 2768749)
Patient Education
Ethosuximide
Ethosuximide is used to control absence seizures (petit mal) (a type of seizure in which there is a very short loss of awareness during which the person may stare straight ahead or blink his eyes and does not respond to others). Ethosuximide is in a class of medications called anticonvulsants. It works by reducing abnormal electrical activity in the brain.
[Learn More]
* Please review the disclaimer below.